• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday

    10/24/22 5:37:02 AM ET
    $ALF
    $APCX
    $ATRA
    $AUID
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALF alert in real time by email

    Gainers

    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) jumped 89.3% to close at $58.92 on Friday.
    • Altamira Therapeutics Ltd. (NASDAQ:CYTO) climbed 58.6% to close at $0.5197 on Friday after the company announced divestiture of its inner ear development assets.
    • Missfresh Limited (NASDAQ:MF) gained 57.5% to close at $2.52.
    • Enservco Corporation (NYSE:ENSV) climbed 37.4% to close at $2.02.
    • Kaleyra, Inc. (NYSE:KLR) gained 24.9% to close at $0.8616.
    • Veris Residential, Inc. (NYSE:VRE) surged 23.3% to close at $15.31 after Kushner Companies made an offer to acquire the company for $16 per share.
    • Matinas BioPharma Holdings, Inc. (NYSE:MTNB) rose 22.2% to settle at $0.8538. Matinas BioPharma announced interim data from the Phase 2 EnACT trial of MAT2203 for the treatment of cryptococcal meningitis, exceeding primary endpoint threshold.
    • Candel Therapeutics, Inc. (NASDAQ:CADL) gained 21.6% to close at $1.80.
    • Energy Focus, Inc (NASDAQ:EFOI) shares climbed 21.5% to close at $0.4900. Energy Focus, last month, named Lesley Matt as CEO.
    • Leju Holdings Limited (NYSE:LEJU) gained 21.1% to settle at $1.61.
    • Rail Vision Ltd. (NASDAQ:RVSN) gained 20.5% to close at $0.5898.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) surged 20.1% to settle at $0.6262.
    • The Boston Beer Company, Inc. (NYSE:SAM) jumped 19.7% to close at $402.28 after the company reported better-than-expected Q3 adjusted EPS and sales results.
    • MacroGenics, Inc. (NASDAQ:MGNX) rose 19.4% to close at $4.80.
    • TuanChe Limited (NASDAQ:TC) climbed 19.1% to settle at $7.87.
    • Zentek Ltd. (NASDAQ:ZTEK) gained 18.9% to close at $1.57.
    • Yunji Inc. (NASDAQ:YJ) rose 18.6% to close at $1.02.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) climbed 18.5% to close at $2.43.
    • Biohaven Ltd. (NYSE:BHVN) gained 17.7% to close at $14.08. Biohaven reported pricing of public offering of 25 million common shares at a price of $10.50 per share.
    • Amprius Technologies, Inc. (NASDAQ:AMPX) climbed 17.6% to close at $11.11. Amprius Technologies was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) gained 17.2% to close at $0.3875.
    • AppTech Payments Corp. (NASDAQ:APCX) gained 16.4% to settle at $0.8849.
    • Pacific Biosciences of California, Inc. (NASDAQ:PACB) climbed 16.3% to close at $7.77.
    • Biotricity, Inc. (NASDAQ:BTCY) rose 15.7% to close at $1.10.
    • uCloudlink Group Inc. (NASDAQ:UCL) rose 15.5% to close at $0.69.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) rose 14.9% to close at $2.70.
    • Microvast Holdings, Inc. (NASDAQ:MVST) surged 13.1% to close at $2.50.
    • Novavax, Inc. (NASDAQ:NVAX) gained 12.6% to close at $19.34 in sympathy with Pfizer, which is reportedly thinking about increasing the price for COVID-19 boosters.
    • Atara Biotherapeutics, Inc. (NASDAQ:ATRA) jumped 12.5% to close at $4.23
    • Piedmont Lithium Inc. (NASDAQ:PLL) rose 12.1% to close at $60.02.
    • 1st Source Corporation (NASDAQ:SRCE) gained 12.1% to close at $55.89.
    • BioNTech SE (NASDAQ:BNTX) climbed 11.2% to close at $131.64 following reports suggesting vaccine makers could possibly raise the prices of COVID-19 shots.
    • Schlumberger Limited (NYSE:SLB) gained 10.3% to close at $50.41 following upbeat quarterly earnings.
    • Calliditas Therapeutics AB (NASDAQ:CALT) gained 10.3% to settle at $12.68 after dipping 15% on Thursday.
    • Super League Gaming, Inc. (NASDAQ:SLGG) gained 10.2% to close at $0.6835.
    • Huntington Bancshares Incorporated (NASDAQ:HBAN) gained 9.5% to close at $14.45 after the company reported better-than-expected Q3 EPS results.
    • Pennsylvania Real Estate Investment Trust (NYSE:PEI) rose 9.4% to close at $2.90.
    • Hawaiian Holdings, Inc. (NASDAQ:HA) shares gained 8.9% to close at $15.33. Hawaiian Airlines announced an agreement with Amazon to operate freighter aircraft.
    • Moderna, Inc. (NASDAQ:MRNA) surged 8.4% to close at $128.32 after SVB Leerink upgraded the stock from Underperform to Market Perform and raised the price target from $74 to $101.
    • Statera Biopharma, Inc. (NASDAQ:STAB) gained 8.2% to close at $0.1658. Statera Biopharma recently signed a binding Memorandum of Understanding with Holobeam Technologies Inc.
    • FedNat Holding Company (NASDAQ:FNHC) gained 6.6% to close at $0.5960 after dipping over 8% on Thursday.

     

    Losers

    • Immunic, Inc. (NASDAQ:IMUX) shares tumbled 77.4% to close at $2.08 on Friday after the company reported the pre-planned Phase 1b interim analysis of IMU-935 in psoriasis patients was confounded by a high placebo rate. Two active arms did not separate from the placebo.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) declined 33.2% to close at $0.2763. NextPlay Technologies recently announced its NextFintech division received commitment for a $15 million strategic investment.
    • Kalera Public Limited Company (NASDAQ:KAL) dropped 32.5% to close at $0.2768.
    • Tenet Healthcare Corporation (NYSE:THC) dipped 31% to close at $37.50 after the company reported worse-than-expected Q3 sales results and issued Q4 and FY22 adjusted EPS and sales guidance below estimates.
    • Snap Inc. (NYSE:SNAP) fell 28.1% to close at $7.76 following Q3 results. The company said it will not provide Q4 expectations due to uncertainties in the operating environment but believes it is likely that year-over-year revenue growth will decelerate as it moves through Q4. The company also said total time spend watching content in the US decreased 5% year over year.
    • authID Inc. (NASDAQ:AUID) dropped 27.5% to close at $1.00.
    • Sientra, Inc. (NASDAQ:SIEN) fell 26.4% to close at $0.29. Sientra recently announced a proposed public offering.
    • SVB Financial Group (NASDAQ:SIVB) dropped 24% to $230.03 after the company reported Q3 earnings results. Following earnings, multiple firms downgraded the stock.
    • Starry Group Holdings, Inc. (NYSE:STRY) fell 22.7% to close at $0.8501. Starry announced a 50% workforce reduction and withdrew FY22 guidance.
    • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) fell 20% to close at $8.00. Kala Pharmaceuticals announced a 1-for-50 reverse stock split.
    • SenesTech, Inc. (NASDAQ:SNES) shares fell 19.5% to close at $0.2253 after declining around 18% on Thursday.
    • COMSovereign Holding Corp. (NASDAQ:COMS) fell 19.5% to close at $0.0808.
    • Quanergy Systems, Inc. (NYSE:QNGY) fell 19.1% to close at $1.53.
    • 9 Meters Biopharma, Inc. (NASDAQ:NMTR) declined 19% to close at $2.18.
    • Eterna Therapeutics Inc. (NASDAQ:ERNA) dropped 18.5% to settle at $3.65.
    • Alfi, Inc. (NASDAQ:ALF) fell 16.1% to close at $0.2432.
    • Rubicon Technologies, Inc. (NYSE:RBT) fell 15.4% to close at $1.92.
    • Katapult Holdings, Inc. (NASDAQ:KPLT) dropped 15.1% to close at $0.9335.
    • Bit Origin Ltd (NASDAQ:BTOG) fell 14.9% to close at $0.2722.
    • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) fell 14.8% to close at $3.35.
    • Community Health Systems, Inc. (NYSE:CYH) dipped 13.9% to close at $2.05.
    • Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) dropped 12.8% to settle at $7.10. Aurinia Pharmaceuticals announced departure of Executive Vice President, Research and Chief Medical Officer.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) dipped 12.1% to settle at $0.4792.
    • Ascent Solar Technologies, Inc. (NASDAQ:ASTI) dropped 10.6% to close at $4.58.
    • Zovio Inc (NASDAQ:ZVO) declined 9.5% to close at $0.1766 after declining 7% on Thursday.
    • First Financial Bankshares, Inc. (NASDAQ:FFIN) dipped 9.1% to close at $39.10. First Finl Bankshares posted Q3 EPS of $0.41.
    • Robert Half International Inc. (NYSE:RHI) shares fell 8.6% to close at $73.01 after reporting downbeat Q3 earnings.
    • Surgery Partners, Inc. (NYSE:SGRY) dropped 7.4% to close at $24.33.
    • Pinterest, Inc. (NYSE:PINS) fell 6.4% to close at $21.50 in sympathy with Snap, which gave an uncertain fourth-quarter outlook.
    • HCA Healthcare, Inc. (NYSE:HCA) fell 5.7% to close at $196.66 after the company reported worse-than-expected Q3 sales results.
    • Twitter, Inc. (NYSE:TWTR) shares fell 4.9% to close at $49.89. The U.S. is reportedly discussing the possibility of subjecting Elon Musk’s companies to national security reviews. Musk has also been locked in a battle over buying Twitter. The U.S. government is reportedly unhappy with the billionaire mobilizing financing from foreign high-net-worth individuals to consummate the deal.
    Get the next $ALF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALF
    $APCX
    $ATRA
    $AUID

    CompanyDatePrice TargetRatingAnalyst
    Immunic Inc.
    $IMUX
    3/24/2026$7.00Buy
    Guggenheim
    Pacific Biosciences of California Inc.
    $PACB
    3/6/2026$1.50Equal Weight → Underweight
    Barclays
    Reviva Pharmaceuticals Holdings Inc.
    $RVPH
    3/5/2026Buy → Hold
    D. Boral Capital
    Pinterest Inc.
    $PINS
    3/2/2026Buy → Hold
    Argus
    Pinterest Inc.
    $PINS
    2/13/2026$16.00Buy → Hold
    Deutsche Bank
    Pinterest Inc.
    $PINS
    2/13/2026$17.00Outperform → Sector Perform
    RBC Capital Mkts
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Overweight → Neutral
    Analyst
    Pinterest Inc.
    $PINS
    2/13/2026$20.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $ALF
    $APCX
    $ATRA
    $AUID
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The $150 Billion Subsurface Intelligence Market Is Still Using Technology from the 1980s. This Defense AI Company Just Published a Research Framework to Change That.

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), Dawson Geophysical (NASDAQ:DWSN), SLB (NYSE:SLB), Geospace Technologies (NASDAQ:GEOS), C3.ai (NYSE:AI) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) announced the completion of an internal research paper evaluating RF-based subsurface sensing architectures, outlining a conceptual framework combining advanced antenna design, edge-based signal processing, and physics-informed computational models for enhanced subsurface visibility.The research initiative follows VisionWave's recently announced Letter of Engagement with the National Oil Company of Liberia for offshore petr

    3/27/26 9:30:00 AM ET
    $AI
    $DWSN
    $GEOS
    Computer Software: Prepackaged Software
    Technology
    Oil & Gas Production
    Energy

    Yunji Announces Second Half and Fiscal Year 2025 Unaudited Financial Results

    HANGZHOU, China, March 27, 2026 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ:YJ), a leading membership-based social e-commerce platform, today announced its unaudited financial results for the second half and fiscal year ended December 31, 20251. Second Half 2025 HighlightsTotal revenues in the second half of 2025 were RMB158.7 million (US$22.7 million), compared with RMB183.8 million in the same period of 2024. The change was primarily due to the Company's continued strategy to refine its product selection across all categories and optimize its selection of suppliers and merchants, together with a deliberate scale-back of the marketplace business.Repeat purchase rate2 in th

    3/27/26 6:00:00 AM ET
    $YJ
    Other Specialty Stores
    Consumer Discretionary

    HCA Healthcare, Inc. 1st Quarter 2026 Earnings Conference Call

    HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2026 Earnings Call When: Friday, April 24, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20260326232305/en/ INVESTOR CONTACT: Frank Morg

    3/26/26 4:00:00 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    $ALF
    $APCX
    $ATRA
    $AUID
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    $ALF
    $APCX
    $ATRA
    $AUID
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Li Dan (Nmn)

    3 - Yunji Inc. (0001759614) (Issuer)

    3/27/26 9:06:45 AM ET
    $YJ
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by De La Chevardiere Patrick

    4 - SLB LIMITED/NV (0000087347) (Issuer)

    3/26/26 4:06:29 PM ET
    $SLB
    Oilfield Services/Equipment
    Energy

    SEC Form 3 filed by new insider Blackwood Nicola Claire

    3 - BioNTech SE (0001776985) (Issuer)

    3/25/26 6:04:48 PM ET
    $BNTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALF
    $APCX
    $ATRA
    $AUID
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $330,182 worth of shares (171,034 units at $1.93) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    3/17/26 8:10:19 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    President, CEO & Chairman Steinour Stephen D bought $499,971 worth of shares (32,277 units at $15.49), increasing direct ownership by 2% to 1,442,845 units (SEC Form 4)

    4 - HUNTINGTON BANCSHARES INC /MD/ (0000049196) (Issuer)

    3/16/26 6:41:11 PM ET
    $HBAN
    Major Banks
    Finance

    Director Edwards Murray Hamilton bought $29,320 worth of shares (1,000 units at $29.32) (SEC Form 4)

    4 - FIRST FINANCIAL BANKSHARES INC (0000036029) (Issuer)

    3/16/26 4:04:26 PM ET
    $FFIN
    Major Banks
    Finance

    $ALF
    $APCX
    $ATRA
    $AUID
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Immunic with a new price target

    Guggenheim initiated coverage of Immunic with a rating of Buy and set a new price target of $7.00

    3/24/26 8:40:25 AM ET
    $IMUX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pacific Biosciences downgraded by Barclays with a new price target

    Barclays downgraded Pacific Biosciences from Equal Weight to Underweight and set a new price target of $1.50

    3/6/26 8:26:02 AM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Reviva Pharmaceuticals downgraded by D. Boral Capital

    D. Boral Capital downgraded Reviva Pharmaceuticals from Buy to Hold

    3/5/26 8:53:11 AM ET
    $RVPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALF
    $APCX
    $ATRA
    $AUID
    SEC Filings

    View All

    SEC Form 20-F filed by uCloudlink Group Inc.

    20-F - uCloudlink Group Inc. (0001775898) (Filer)

    3/27/26 4:01:36 PM ET
    $UCL
    Telecommunications Equipment
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Veris Residential Inc.

    SCHEDULE 13G/A - Veris Residential, Inc. (0000924901) (Subject)

    3/27/26 1:54:43 PM ET
    $VRE
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Tenet Healthcare Corporation

    SCHEDULE 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)

    3/27/26 1:35:42 PM ET
    $THC
    Hospital/Nursing Management
    Health Care

    $ALF
    $APCX
    $ATRA
    $AUID
    Leadership Updates

    Live Leadership Updates

    View All

    Surgery Partners, Inc. Names Lloyd Dean to Board of Directors

    BRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean ser

    3/12/26 6:12:07 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Protiviti Announces Winners of Second Annual Audit Innovator Award

    MENLO PARK, Calif., March 10, 2026 /PRNewswire/ -- Protiviti, a global consulting firm, today announced the winners of its second annual Audit Innovator Award, recognizing internal audit leaders and functions who are redefining the profession through bold strategy, cutting-edge technology, and people-centered transformation. Andrew Struthers-Kennedy, Protiviti's Global CAE Solutions Leader, presented the awards during the Institute of Internal Auditors' Great Audit Minds (GAM) conference. The awards are also supported by The Institute of Internal Auditors and Optro (formerly Aud

    3/10/26 11:58:00 AM ET
    $RHI
    Professional Services
    Consumer Discretionary

    PacBio Announces the Appointment of Chris Gibson to the Board of Directors

    MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher Gibson, Ph.D., to PacBio's Board of Directors. Dr. Gibson is the co-founder and Chairman of the Board of Directors of Recursion (NASDAQ:RXRX), a clinical-stage biotechnology company that has built one of the industry's most advanced AI-driven drug discovery platforms. Under his leadership, Recursion integrated large-scale biological data generation with machine learning to industrialize the discovery process, building a vertically integrated technology stack spanning automation, high-dimensional b

    3/5/26 8:30:00 AM ET
    $PACB
    $RXRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALF
    $APCX
    $ATRA
    $AUID
    Financials

    Live finance-specific insights

    View All

    Yunji Announces Second Half and Fiscal Year 2025 Unaudited Financial Results

    HANGZHOU, China, March 27, 2026 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ:YJ), a leading membership-based social e-commerce platform, today announced its unaudited financial results for the second half and fiscal year ended December 31, 20251. Second Half 2025 HighlightsTotal revenues in the second half of 2025 were RMB158.7 million (US$22.7 million), compared with RMB183.8 million in the same period of 2024. The change was primarily due to the Company's continued strategy to refine its product selection across all categories and optimize its selection of suppliers and merchants, together with a deliberate scale-back of the marketplace business.Repeat purchase rate2 in th

    3/27/26 6:00:00 AM ET
    $YJ
    Other Specialty Stores
    Consumer Discretionary

    HCA Healthcare, Inc. 1st Quarter 2026 Earnings Conference Call

    HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2026 Earnings Call When: Friday, April 24, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20260326232305/en/ INVESTOR CONTACT: Frank Morg

    3/26/26 4:00:00 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    SLB Announces Dates for First-Quarter 2026 Results Conference Call

    SLB (NYSE:SLB) will hold a conference call on April 24, 2026, to discuss the results for the first quarter ending March 31, 2026. The conference call is scheduled to begin at 11:00 a.m. US Eastern time and a press release regarding the results will be issued at 7:00 a.m. US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (833) 470-1428 within North America or +1 (404) 975-4839 outside of North America approximately 10 minutes prior to the start of the call and the access code is 742955. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/972985185 on a listen-only basis. Listene

    3/26/26 1:00:00 PM ET
    $SLB
    Oilfield Services/Equipment
    Energy

    $ALF
    $APCX
    $ATRA
    $AUID
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Candel Therapeutics Inc.

    SC 13G - Candel Therapeutics, Inc. (0001841387) (Subject)

    12/17/24 12:30:40 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13G/A filed by Pinterest Inc.

    SC 13G/A - PINTEREST, INC. (0001506293) (Subject)

    12/6/24 10:11:26 AM ET
    $PINS
    Computer Software: Programming Data Processing
    Technology